Trial Profile
Phase II study of oral vinorelbine as neoadjuvant treatment in patients with locally advanced breast cancer older than 60 years
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 Aug 2011
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary)
- Indications Early breast cancer
- Focus Therapeutic Use
- Sponsors Pierre Fabre
- 31 Aug 2011 New trial record